BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12042708)

  • 1. Molecular diagnosis of lymphoid malignancies by gene expression profiling.
    Davis RE; Staudt LM
    Curr Opin Hematol; 2002 Jul; 9(4):333-8. PubMed ID: 12042708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical translation of gene expression profiling in lymphomas and leukemias.
    Rosenwald A; Staudt LM
    Semin Oncol; 2002 Jun; 29(3):258-63. PubMed ID: 12063678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA microarrays in lymphoid malignancies.
    Rosenwald A
    Oncology (Williston Park); 2003 Dec; 17(12):1743-8; discussion 1750, 1755, 1758-9 passim. PubMed ID: 14723013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards molecular diagnosis and targeted therapy of lymphoid malignancies.
    Wiestner A; Staudt LM
    Semin Hematol; 2003 Oct; 40(4):296-307. PubMed ID: 14582080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling of lymphoid malignancies.
    Staudt LM
    Annu Rev Med; 2002; 53():303-18. PubMed ID: 11818476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling data in lymphoma and leukemia: review of the literature and extrapolation of pertinent clinical applications.
    Dunphy CH
    Arch Pathol Lab Med; 2006 Apr; 130(4):483-520. PubMed ID: 16594743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling in malignant lymphomas.
    Henrickson SE; Hartmann EM; Ott G; Rosenwald A
    Adv Exp Med Biol; 2007; 593():134-46. PubMed ID: 17265723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic significance of gene expression profiling in lymphomas.
    Leich E; Hartmann EM; Burek C; Ott G; Rosenwald A
    APMIS; 2007 Oct; 115(10):1135-46. PubMed ID: 18042147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DNA-chips in the diagnosis of hematological malignancies].
    Feuring-Buske M; Hartmann EM; Ott G; Reuter H; Buske C; Rosenwald A
    Internist (Berl); 2006 Jan; 47(1):39-46. PubMed ID: 16247632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphomas: its gene expression profiling.
    Tiwari M
    J Cancer Res Ther; 2011; 7(4):393-8. PubMed ID: 22269398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression analysis in aggressive NHL.
    Chan WC; Huang JZ
    Ann Hematol; 2001; 80 Suppl 3():B38-41. PubMed ID: 11757704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
    Tagawa H
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells.
    Davis RE; Brown KD; Siebenlist U; Staudt LM
    J Exp Med; 2001 Dec; 194(12):1861-74. PubMed ID: 11748286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling in lymphoma diagnosis and management.
    Iqbal J; Liu Z; Deffenbacher K; Chan WC
    Best Pract Res Clin Haematol; 2009 Jun; 22(2):191-210. PubMed ID: 19698928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
    Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
    J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of seven genes, as potential markers, for the differential diagnosis of small B cell lymphomas (small lymphocytic lymphoma, marginal zone B cell lymphoma and mantle cell lymphoma) by cDNA macroarrays analysis.
    Thieblemont C; Chettab K; Felman P; Callet-Bauchu E; Traverse-Glehen A; Berger F; Dumontet C; Cerutti C; Baseggio L; Salles G; Paultre C; Coiffier B; McGregor JL
    Leukemia; 2002 Nov; 16(11):2326-9. PubMed ID: 12399979
    [No Abstract]   [Full Text] [Related]  

  • 17. Discussion of the applicability of microarrays: profiling of leukemias.
    Haferlach T; Bacher U; Kohlmann A; Haferlach C
    Methods Mol Biol; 2009; 509():15-33. PubMed ID: 19212712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular abnormalities in lymphomas].
    Delsol G
    Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approaches to lymphoma diagnosis.
    Harris NL; Stein H; Coupland SE; Hummel M; Favera RD; Pasqualucci L; Chan WC
    Hematology Am Soc Hematol Educ Program; 2001; ():194-220. PubMed ID: 11722985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular biology of lymphoma in the microarray era.
    Catalano A; Iland H
    Pathology; 2005 Dec; 37(6):508-22. PubMed ID: 16373230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.